MGMT and glioma: O6‐methylguanine‐DNA‐methyltransferase (MGMT) promoter methylation serves as a significant molecular marker for assessing the therapeutic efficacy of alkylating agents like temozolomide, which is a first‐line chemotherapy drug for glioma.117